News archive
374 results
Introducing a dedicated website section for substances of human origin
Language requirements to be simplified for common Nordic packages for hospital products
Fimea designates a third notified body under the IVD Regulation in Finland, strengthening Finland’s status as one of the leading EU countries by the number of notified bodies
Attention medical device operators: check the information submitted to the register by 31 December 2025
Nearly half of Finns with chronic conditions find medication therapy a burden
There’s still time to sign up for the information session for marketing authorisation holders on 30 October
A new online tool helps operators assess whether the obligations of the NIS2 Directive apply to them
Medicines are not sweets: read the package leaflet and follow the instructions
Media visibility and costs of new medicines under examination – what does the media highlight?
Watch out for fake online pharmacies – be careful where you shop
National networks coordinated by Fimea to be merged from the beginning of 2026
Fimea’s E-service can now be accessed in one place
Fimea issues a warning: Plenty of scam advertisements now spreading online
Fimea to investigate the conformity of software-based medical devices
New application to improve management of clinical trials
Marketing authorisation for Litalgin products cancelled for safety reasons in summer 2024 – these products should no longer be used
2024 annual report on the supervision of the quality and safety of substances of human origin has been published
Fimea’s sustainability report for 2024 has been published
Cross-border ePrescription is perceived to improve access to medicines, tools are needed for patient counselling to improve medication safety
Mesalazine-containing enteric-coated tablets are in short supply
Showing 21 - 40 / 374
